Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.
Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ
EMBO J. 2005 Jan 26. 24(2):368-81.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 8878 | 3788 pmko-neo A9-1 | |
| 8880 | 3788 pmko-neo A9-3 | |
| 8881 | 3789 pmko-neo RNAi-GFP |